The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMERI.L Regulatory News (MERI)

  • There is currently no data for MERI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

30 Aug 2019 07:00

RNS Number : 6326K
Merian Chrysalis Investment Co. Ltd
30 August 2019
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than the United Kingdom and the Republic of Ireland), Canada, Australia, Japan or the Republic of South Africa.

 

Merian Chrysalis Investment Company Limited

30 August 2019

 

 

Merian Chrysalis Investment Company Limited (the "Company")

 

NAV Announcement

 

 

Net Asset Value

The Company announces that as at 30 June 2019 the unaudited net asset value ("NAV") per ordinary share was 111.16 pence.

 

The above NAV calculation is based on the Company's issued share capital as at 30 June 2019 of 190,909,091 ordinary shares of no par value.

 

Following the successful raise of £100 million (gross) in April, at a price of 110 pence per share, approximately 49.9 per cent of the Company's capital was held in cash or cash equivalents as at 30 June 2019.

 

As the Company previously advised, TransferWise closed a significant funding round in May this year. The valuation uplift on this transaction resulted in an increase of approximately 8.9 pence per share to the Company's NAV per ordinary share and was reflected in Company's NAV as at 31 March 2019. Given the proximity of the completion of the funding round to the period end, the valuation of TransferWise was held for the 30 June 2019 NAV calculation. The holding in TransferWise represented approximately 12.7 per cent of the Company's capital as at 30 June 2019.

The Company confirms that its new investments in Embark Group, Klarna Holding AB and Sorted Holdings Limited completed in July and August 2019 and are therefore post the period end for the purposes of calculating the NAV.

 

Revenue growth

 

In the first half of 2019, the weighted average revenue growth rate of the nine companies within the portfolio was in excess of 50 per cent over the first half of 2018.

 

Pipeline

Following a number of recent investments, the Company is now approximately 80 per cent fully invested and has a strong pipeline of exciting opportunities. As such, the Company will look to raise additional capital under its placing programme in the near future.

 

Factsheet

 

A Company factsheet will be available shortly on the Company's website: https://www.merian.com/chrysalis/

 

Richard Watts, portfolio manager, commented:

 

"Demand for Merian Chrysalis has continued to grow over 2019 as investors seek access to Europe's most disruptive and exciting private companies. We are establishing a strong track record of successfully accessing and executing high-profile deal flow and we are very confident of our ability to continue to swiftly deploy capital."

 

 

-ENDS-

 

 

For further information, please contact:

 

Merian Global Investors:

Amelie Shepherd

 

 

 

+44 (0) 20 7332 7500

 

Liberum:

Gillian Martin / Owen Matthews

 

+44 (0) 20 3100 2000

Maitland Administration (Guernsey) Limited:

Aimee Gontier / Elaine Smeja

+44 (0) 1481 749364

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.merian.com/chrysalis/.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVPGURCRUPBPUB
Date   Source Headline
18th Dec 202012:18 pmRNSResults of Extraordinary General Meeting
17th Dec 20204:38 pmRNSDirector Declaration
11th Dec 20207:00 amRNSNet Asset Value(s)
27th Nov 20203:03 pmRNSDirector/PDMR Shareholding
27th Nov 20203:02 pmRNSDirector/PDMR Shareholding
25th Nov 20203:38 pmRNSProposed Change of Name
8th Oct 20204:23 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSResults of Capital Raise
6th Oct 202011:20 amRNSUpdate on Placing
1st Oct 20207:00 amRNSPortfolio Update
28th Sep 202010:07 amRNSPrimaryBid.com Offer
28th Sep 202010:00 amRNSProposed Placing of Equity
22nd Sep 20205:05 pmRNSHolding(s) in Company
16th Sep 20209:11 amRNSPortfolio Update
15th Sep 20208:58 amRNSPortfolio Update
11th Sep 20207:00 amRNSPortfolio Update
10th Sep 20204:41 pmRNSSecond Price Monitoring Extn
10th Sep 20204:36 pmRNSPrice Monitoring Extension
10th Sep 202012:07 pmRNSSecond Price Monitoring Extn
10th Sep 202012:02 pmRNSPrice Monitoring Extension
8th Sep 202012:07 pmRNSSecond Price Monitoring Extn
8th Sep 202012:02 pmRNSPrice Monitoring Extension
2nd Sep 202012:07 pmRNSSecond Price Monitoring Extn
2nd Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSNet Asset Value(s)
29th Jul 20207:00 amRNSPortfolio Update
20th Jul 20207:00 amRNSPortfolio Update
6th Jul 202012:31 pmRNSHolding(s) in Company
6th Jul 202012:28 pmRNSHolding(s) in Company
26th Jun 20207:00 amRNSInterim Accounts to 31 March 2020
23rd Jun 202012:08 pmRNSSecond Price Monitoring Extn
23rd Jun 202012:02 pmRNSPrice Monitoring Extension
22nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20204:35 pmRNSPrice Monitoring Extension
27th May 20207:00 amRNSQuarterly NAV and COVID-19 Portfolio Update
13th May 202012:07 pmRNSSecond Price Monitoring Extn
13th May 202012:02 pmRNSPrice Monitoring Extension
13th May 20207:00 amRNSPortfolio Update
7th May 20204:40 pmRNSSecond Price Monitoring Extn
7th May 20204:35 pmRNSPrice Monitoring Extension
6th May 202012:08 pmRNSSecond Price Monitoring Extn
6th May 202012:02 pmRNSPrice Monitoring Extension
30th Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 202012:08 pmRNSSecond Price Monitoring Extn
15th Apr 202012:02 pmRNSPrice Monitoring Extension
9th Apr 202012:07 pmRNSSecond Price Monitoring Extn
9th Apr 202012:03 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSStatement relating to COVID-19
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.